According to Olin Biotech's announcement, Taichang Group, a shareholder holding more than 5% of the company's shares, holds 258.93.4 million shares, accounting for 6.39% of the company's total share capital. Taichang Group completed the pledge cancellation procedure for 600,000 shares on November 6, 2026. The unpledged shares accounted for 2.32% of the total number of shares held and 0.15% of the company's total share capital. After the release of the pledge of some of the shares was completed, Taichang Group pledged a total of 15.81 million shares of the company, accounting for 61.06% of its total shareholding and 3.90% of the company's total share capital.

According to Olin Biotech's announcement, Taichang Group, a shareholder holding more than 5% of the company's shares, holds 258.93.4 million shares, accounting for 6.39% of the company's total share capital. Taichang Group completed the pledge cancellation procedure for 600,000 shares on November 6, 2026. The unpledged shares accounted for 2.32% of the total number of shares held and 0.15% of the company's total share capital. After the release of the pledge of some of the shares was completed, Taichang Group pledged a total of 15.81 million shares of the company, accounting for 61.06% of its total shareholding and 3.90% of the company's total share capital.